Skip to main content
. Author manuscript; available in PMC: 2016 Dec 1.
Published in final edited form as: Thromb Res. 2015 Oct 17;136(6):1165–1168. doi: 10.1016/j.thromres.2015.10.022

Table 3.

Timing of aCVD and VTE occurrences among women with and without polycystic ovary syndrome.

aCVD Outcome N (total) PCOS N (total) No PCOS Fisher's exact P value
Occurred before VTE (%) Occurred after VTE (%) Occurred before VTE (%) Occurred after VTE (%)
Ischemic stroke 35 48.6 51.4 31 77.4 22.6 0.02
Acute myocardial infarction   8 37.5 62.5 15 80.0 20.0 0.07
Peripheral vascular disease 28 57.1 42.9 18 77.8 22.2 0.21
Any aCVD 68 48.5 51.5 60 76.7 23.3 0.002

aCVD, atherosclerotic cardiovascular disease; VTE, venous thromboembolism; PCOS, polycystic ovary syndrome.